Segment Information (Tables)

6 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Financial Information for Business Segments

The following is the summary of the financial information for the Company’s operating and reportable segments for the three and six months ended March 31, 2018 and 2017 and balances as of March 31, 2018 and 2017(in thousands):

	Brooks
	Semiconductor		Brooks
	Solutions Group		Life Sciences		Total
Three Months Ended March 31, 2018:
Revenue
Products	$	137,025	$	23,466	$	160,491
Services		21,696		25,073		46,769
Segment revenue	$	158,721	$	48,539	$	207,260
Gross profit	$	65,299	$	18,930	$	84,229
Segment operating income		30,836		2,683		33,519
Depreciation expense		1,133		2,039		3,172
Three Months Ended March 31, 2017:
Revenue
Products	$	115,634	$	16,979	$	132,613
Services		19,031		17,689		36,720
Segment revenue	$	134,665	$	34,668	$	169,333
Gross profit	$	51,325	$	13,199	$	64,524
Segment operating income		20,003		1,290		21,293
Depreciation expense		1,319		1,045		2,364
Six Months Ended March 31, 2018:
Revenue
Products	$	257,228	$	45,447	$	302,675
Services		43,379		50,534		93,913
Segment revenue	$	300,607	$	95,981	$	396,588
Gross profit	$	124,752	$	34,692	$	159,444
Segment operating income		57,198		2,543		59,741
Depreciation expense		2,282		3,588		5,870
Six Months Ended March 31, 2017:
Revenue
Products	$	225,029	$	29,698	$	254,727
Services		36,252		38,309		74,561
Segment revenue	$	261,281	$	68,007	$	329,288
Gross profit	$	96,794	$	24,673	$	121,467
Segment operating income		37,374		1,402		38,776
Depreciation expense		2,595		2,135		4,730
Assets:
March 31, 2018	$	353,654	$	385,025	$	738,679
September 30, 2017		325,408		306,666		632,074

Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts

The following is a reconciliation of the Company’s operating and reportable segments’ operating income and segment assets to the corresponding amounts presented in the accompanying unaudited Consolidated Statements of Operations for the three and six months ended March 31, 2018 and 2017 and Consolidated Balance Sheets as of March 31, 2018 and September 30, 2017 (in thousands):

		Three Months Ended			Six Months Ended
		March 31,			March 31,
	2018		2017		2018		2017
Segment operating income	$	33,519	$	21,293	$	59,741	$	38,776
Amortization of acquired intangible assets		4,629		3,294		9,218		6,358
Restructuring charges		49		860		49		1,835
Other unallocated corporate expenses		5,022		2,338		5,815		2,620
Total operating income	$	23,819	$	14,801	$	44,659	$	27,963

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

	March 31,		September 30,
	2018		2017
Segment assets	$	738,679	$	632,074
Cash, cash equivalents and marketable securities		245,179		104,292
Deferred tax assets		47,572		1,692
Equity method investments		35,111		28,570
Total assets	$	1,066,541	$	766,628